These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27618021)

  • 1. Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
    Mlakar V; Huezo-Diaz Curtis P; Satyanarayana Uppugunduri CR; Krajinovic M; Ansari M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merika E; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pharmacogenomics on clinical practice in oncology.
    Marsh S
    Mol Diagn Ther; 2007; 11(2):79-82. PubMed ID: 17397243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy.
    Stojiljkovic M; Fazlagic A; Dokmanovic-Krivokapic L; Nikcevic G; Patrinos GP; Pavlovic S; Zukic B
    Hum Genomics; 2012 Sep; 6(1):19. PubMed ID: 23157848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthetic considerations for the pediatric oncology patient--part 1: a review of antitumor therapy.
    Latham GJ; Greenberg RS
    Paediatr Anaesth; 2010 Apr; 20(4):295-304. PubMed ID: 20470332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision making in pediatric oncology: evaluation and incorporation of patient and parent preferences.
    Sung L; Regier DA
    Pediatr Blood Cancer; 2013 Apr; 60(4):558-63. PubMed ID: 23281255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy.
    Nogueiras-Álvarez R; Pérez Francisco I
    Br J Clin Pharmacol; 2024 Oct; 90(10):2483-2508. PubMed ID: 39077855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
    Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
    Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development.
    Rioux N; Waters NJ
    Drug Metab Dispos; 2016 Jul; 44(7):934-43. PubMed ID: 26936973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future of clinical genomics in pediatric oncology.
    Janeway KA; Place AE; Kieran MW; Harris MH
    J Clin Oncol; 2013 May; 31(15):1893-903. PubMed ID: 23589558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics: personalizing pediatric heart transplantation.
    Van Driest SL; Webber SA
    Circulation; 2015 Feb; 131(5):503-12. PubMed ID: 25645611
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers.
    Lee JW; Pussegoda K; Rassekh SR; Monzon JG; Liu G; Hwang S; Bhavsar AP; Pritchard S; Ross CJ; Amstutz U; Carleton BC;
    Ther Drug Monit; 2016 Aug; 38(4):423-31. PubMed ID: 26960170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It's not easy being small.
    Adamson PC
    Pediatr Blood Cancer; 2010 Mar; 54(3):341-3. PubMed ID: 19908300
    [No Abstract]   [Full Text] [Related]  

  • 19. Conference scene: pharmacogenomics: from cell to clinic (part 2).
    Siest G; Medeiros R; Melichar B; Stathopoulou M; Van Schaik RH; Cacabelos R; Abt PM; Monteiro C; Gurwitz D; Queiroz J; Mota-Filipe H; Ndiaye NC; Visvikis-Siest S
    Pharmacogenomics; 2014 Apr; 15(6):739-44. PubMed ID: 24897282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine.
    Squassina A; Severino G; Grech G; Fenech A; Borg J; Patrinos GP
    Pharmacogenomics; 2012 Apr; 13(5):525-8. PubMed ID: 22462744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.